全文获取类型
收费全文 | 244篇 |
免费 | 18篇 |
专业分类
儿科学 | 9篇 |
妇产科学 | 10篇 |
基础医学 | 16篇 |
口腔科学 | 56篇 |
临床医学 | 14篇 |
内科学 | 39篇 |
皮肤病学 | 3篇 |
神经病学 | 8篇 |
特种医学 | 3篇 |
外科学 | 39篇 |
综合类 | 2篇 |
预防医学 | 23篇 |
眼科学 | 24篇 |
药学 | 6篇 |
肿瘤学 | 10篇 |
出版年
2021年 | 6篇 |
2020年 | 6篇 |
2019年 | 2篇 |
2018年 | 15篇 |
2017年 | 4篇 |
2016年 | 10篇 |
2015年 | 7篇 |
2014年 | 9篇 |
2013年 | 13篇 |
2012年 | 5篇 |
2011年 | 12篇 |
2010年 | 4篇 |
2008年 | 12篇 |
2007年 | 9篇 |
2006年 | 11篇 |
2005年 | 9篇 |
2004年 | 7篇 |
2003年 | 7篇 |
2002年 | 9篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 7篇 |
1996年 | 3篇 |
1994年 | 1篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1979年 | 5篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1973年 | 4篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1970年 | 7篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 4篇 |
1966年 | 1篇 |
1965年 | 4篇 |
1964年 | 1篇 |
1961年 | 3篇 |
1958年 | 1篇 |
排序方式: 共有262条查询结果,搜索用时 0 毫秒
51.
María Fernanda Álvarez Barreneche Carlos Andrés Restrepo Castro Alicia Hidrón Botero Juan Pablo Villa Franco Ivan Mauricio Trompa Romero Laura Restrepo Carvajal Alejandro Eusse García Adriana Ocampo Mesa Lina María Echeverri Toro Glenys Patricia Porras Fernández de Castro Jaime Mauricio Ramírez Rivera Carlos Andrés Agudelo Restrepo 《AIDS research and therapy》2017,14(1):60
Background
Antiretroviral therapy (ART) has modified the natural history of HIV-infection: the incidence of opportunistic infections (OIs) has decreased and mortality associated to HIV has improved dramatically. The reasons for hospitalization have changed; OIs are no longer the most common reason for admission. This study describes the patient population, admission diagnosis and hospital course of HIV patients in Colombia in the ART era.Methods
Patients admitted with HIV/AIDS at six hospitals in Medellin, Colombia between August 1, 2014 and July 31, 2015 were included. Demographic, laboratory, and clinical data were prospectively collected.Results
551 HIV-infected patients were admitted: 76.0% were male, the median age was 37 (30–49). A new diagnosis of HIV was made in 22.0% of patients during the index admission. 56.0% of patients of the entire cohort had been diagnosed with HIV for more than 1 year and 68.9% were diagnosed in an advanced stage of the disease. More than 50.0% of patients had CD4 counts less than 200 CD4 cells/μL and viral loads greater than 100,000 copies. The main reasons for hospital admissions were OIs, tuberculosis, esophageal candidiasis and Toxoplasma encephalitis. The median hospital stay was 14 days (IQR 8–23). Admission to the intensive care unit (ICU) was required in 10.3% of patients and 14.3% were readmitted to the hospital; mortality was 5.4%.Conclusions
Similar to other countries in the developing world, in Colombia, the leading cause of hospitalization among HIV-infected patients remain opportunistic infections. However, in-hospital mortality was low, similar to those described for high-income countries. Strategies to monitor and optimize the adherence and retention in HIV programs are fundamental to maximize the benefit of ART.52.
53.
Lambertucci Adriana Carneiro Lofrano-Prado Mara Cristina Lambertucci Rafael Herling Botero João Paulo Dâmaso Ana Raimunda do Prado Wagner Luiz 《Sport Sciences for Health》2022,18(2):407-414
Sport Sciences for Health - The aim of the present study was to compare the effects 24 weeks of counseling-based therapy with or without recreational physical activity (RPA) on adipokines,... 相似文献
54.
55.
56.
AIM: To determine whether commonly used endodontic sealers could either induce or increase the release of prostaglandin E2 (PGE2) when in contact with cell types found in the periapical tissues. METHODOLOGY: Freshly mixed samples of Roth 801 sealer, Sealapex and ProRoot mineral trioxide aggregate (MTA) were placed in contact with cultured macrophages and fibroblasts for 24 h. The supernatant from the cultures was assayed for PGE2 using enzyme-linked immunosorbent assay. Cell viability counts were made. As a positive control, similar cultures were also exposed to lipopolysaccharide and the supernatant analysed for PGE2. Data were compared by anova. RESULTS: The three materials examined in these experiments did not stimulate increased PGE2 release from either of the cell lines. In control cultures, lipopolysaccharide increased PGE2 release from macrophages but not from fibroblasts. Viability counts revealed that, whilst Roth 801 sealer caused some cell death in both fibroblasts and macrophages, Sealapex led to cell death only in the macrophage cultures. ProRoot MTA did not lead to statistically significant cell death in either culture. CONCLUSIONS: Under 24-h culture conditions, the three freshly mixed test materials did not increase directly either production or release of PGE2 from either macrophages or gingival fibroblasts. Roth 801 decreased cell viability counts for both fibroblasts and macrophages. Sealapex decreases macrophage viability. ProRoot MTA did not affect viability in either cell line. 相似文献
57.
Wei SJ Botero A Hirota K Bradbury CM Markovina S Laszlo A Spitz DR Goswami PC Yodoi J Gius D 《Cancer research》2000,60(23):6688-6695
58.
Alberth M Majoros L Kovalecz G Borbás E Szegedi I J Márton I Kiss C 《Pathology oncology research : POR》2006,12(4):237-241
Candidiasis is common in children with cancer, particularly during periods of severe immunosuppression and neutropenia. Our aim was to study the microbiological changes in the oral cavity of children with newly diagnosed cancer. The study group consisted of 30 consecutive children and adolescents, 16 with acute lymphoblastic leukemia and 14 with solid tumors. Oral cultures to detect fungi and bacteria were conducted for all patients before treatment, during and after neutropenic episodes. In 23 patients developing fever simultaneous throat, urine and blood sampling was carried out. No pathogens were found in the cultures taken before the outset (30 cultures) or after recovery from (30 cultures) the neutropenic episodes. In the 45 oral cultures taken during the neutropenic episodes 38 (84.4%) proved positive. Fungi were the most frequently isolated oral pathogens: 33/38 yeast and 6/38 bacterial infections were identified. There was no association between the underlying malignancy and the occurrence of the positive cultures. Of the 30 patients, all 23 (76.7%) who have developed moderate-to-severe neutropenia, developed oral fungal colonization or clinically obvious fungal infection at least on one occasion during the study. In addition to oral samples, fungi were identified in 9/23 pharyngeal swabs, 6/23 urine and 1/23 blood cultures. The initial fungal pathogen was exclusively (33/33) Candida albicans. In extended severe neutropenic states, C. albicans was replaced by non-albicans species (C. kefyr, C. lusitaniae, C. sake, C. tropicalis) in 5 patients between 4 to 6 days of the neutropenic episodes. Four of the nonalbicans Candida strains were resistant to azole-type antifungal agents. Neutropenic episodes of children with cancer are associated with an increased risk of developing oral and even systemic infections with C. albicans that can be replaced by azole-resistant nonalbicans strains in prolonged neutropenia contributing to morbidity of these patients. 相似文献
59.
Graziano KU Balsamo AC Lopes Cde L Zotelli MF Couto AT Paschoal ML 《Revista latino-americana de enfermagem》2006,14(1):70-76
In this study, we elaborated criteria to evaluate difficulties in cleaning single-use articles (SVA), which will be used for decision making about investments in the validation of reuse protocols. This methodological research was carried out at a University Hospital and aimed to: identify SVA used and reused at the institution; propose an instrument to measure risk levels of SVA for cleaning; classify SVA using 9 criteria established in the proposed instrument and evaluate its applicability. We identified 32 SVA, whose risks were classified using the colors used in traffic lights, with a view to supporting decision making about reuse. The proposed criteria make it possible to diagnose the risk of cleaning the SVA under analysis, as well as their implications for the safety of the sterilization process. 相似文献
60.
Botero RC 《Transplantation proceedings》2004,36(5):1449-1454
Chronic hepatitis C (HCV) infection affects more than 170 million people throughout the world and 2 to 3 million Americans. End-stage liver disease secondary to chronic HCV infection is the most frequent indication for liver transplantation in this country. Currently, the gold standard for treatment for immunocompetent patients is a combination of peginterferon (PEG-IFN) and ribavirin for 6 to 12 months depending on the genotype. This treatment achieves a sustained virological response (SVR) in 54% to 61% of patients overall. Almost 50% of patients do not respond or have recurrences posttreatment and progress in over 10 to 20 years into chronic liver disease and its complications. Liver transplantation is the only therapeutic modality that impacts on quality of life and survival of these patients. However, recurrence of HCV in the new allograft is universal with accelerated progression to cirrhosis in 5 to 10 years. Response to treatment is usually low (20% to 30%), and associated with significant side effects and depression. A significant percentage of patients with recurrent HCV after transplantation require retransplantation to control the complications of end-stage liver disease. Other solid organ transplants recipients already HCV-positive, or infected at the time of transplantation from blood transfusions or an infected graft, develop accelerated, progressive liver disease facilitated by the adverse effects of immunosuppression in addition to HCV replication. To prevent morbidity, mortality, and high costs related to the consequences of HCV infection, all solid organ transplant candidates should be tested for HCV infection and treated appropriately with PEG-IFN and ribavirin prior to transplantation. 相似文献